Advertisement

Search Results

Advertisement



Your search for Thomas A. Abrams, MD matches 4 pages

Showing 1 - 4


hepatobiliary cancer

Ramucirumab After Sorafenib in Advanced Hepatocellular Carcinoma: An Efficacious Therapy With Applicability Challenges

In the 2 years since the U.S. Food and Drug Administration’s (FDA) approval of regorafenib in the treatment of patients with sorafenib-refractory advanced hepatocellular carcinoma, we oncologists have witnessed a veritable avalanche of newly approved medicines for the treatment of advanced...

Roswell Park Graduate Student Honored by National Cancer Institute

Roswell Park Cancer Institute graduate student Danielle Twum has received the prestigious Emerging Scholars Award from the National Cancer Institute (NCI), who recognized her among the distinguished alumni of its Continuing Umbrella for Research Excellence (CURE) programs. The CURE programs are...

American Society of Hematology Honors David Grimwade, PhD, Posthumously With the 2016 Exemplary Service Award

The American Society of Hematology (ASH) will recognize the late David Grimwade, PhD, formerly of King’s College London and Guy’s and St. Thomas’ NHS Foundation Trust with the 2016 Exemplary Service Award for his exceptional years of service and dedication to the Society’s global programs that...

colorectal cancer

For Metastatic Colorectal Cancer, Bevacizumab Is More Commonly Included Than Anti-EGFR Antibody Therapies

Analysis of a large cohort of patients with metastatic colorectal cancer who received chemotherapy at academic, private, and community-based oncology practices using the same chemotherapy order entry system showed that “bevacizumab has been more consistently integrated into treatment regimens than...

Advertisement

Advertisement



;
Advertisement